Daily functional electrical stimulation during everyday walking activities improves performance and satisfaction in children with unilateral spastic cerebral palsy: a randomized controlled trial by Dayna Pool et al.
Pool et al. Archives of Physiotherapy  (2015) 5:5 
DOI 10.1186/s40945-015-0005-xRESEARCH ARTICLE Open AccessDaily functional electrical stimulation during
everyday walking activities improves
performance and satisfaction in children
with unilateral spastic cerebral palsy:
a randomized controlled trial
Dayna Pool1*, Jane Valentine2, A. Marie Blackmore3, Jennifer Colegate4, Natasha Bear1, Katherine Stannage5
and Catherine Elliott6Abstract
Background: The aim of this paper is to determine whether daily functional electrical stimulation (FES) is effective
in improving self-perceptions of individually identified mobility performance problems in children with unilateral
spastic cerebral palsy (USCP). We hypothesized that children receiving 8 weeks of FES treatment would have higher
scores for self-perceived performance and satisfaction on the Canadian Occupational Performance Measure (COPM)
for individually identified priorities than children not receiving FES.
Methods: Thirty-two children (mean age 10 y 8 mo SD 3y 3mo) with USCP and a Gross Motor Function Classification
System I or II were randomly assigned to the FES treatment group (8 weeks of daily FES) and control group (usual
treatments). Participants were assessed at baseline (week 0), post treatment (week 8) and 6 weeks follow-up
(week 14). The primary outcome measures were self-perceived scores for performance and satisfaction of child- and
parent-identified priorities assessed using the COPM post treatment and at follow-up. The secondary outcome
measures were the categorization of the performance problems from the COPM and self-report responses according to
the International Classification of Functioning Child and Youth version (ICF-CY). This was clinically important because an
understanding of mobility performance problems for children with USCP is needed for family-centred service planning.
Results: Performance scores (mean difference 1.6, 95 % CI 0.1 to 3.2, p = 0.034) and satisfaction scores post treatment
(mean difference 2.4, 95 % CI 0.5 to 4.2, p = 0.004) were significantly higher in the treatment group than in the control
group. There were no significant differences between the groups for performance scores at follow up, however there
was a significant difference between the groups for satisfaction (mean difference 1.9, 95 % CI 0.1 to 3.8, p = 0.03) in
favour of the treatment group. Priorities were identified across all levels of the ICF-CY but were most commonly
identified in the activity and participation domains of the ICF-CY (79.5 %).
Conclusions: Daily FES applied during everyday walking is effective in addressing self-perceptions of individually
identified priorities by improving the performance and satisfaction of functional skills after treatment.
Trial registration: Australian New Zealand Clinical Trials Register ACTRN12614000949684. Registered 4 September 2014.
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Cerebral palsy describes a group of permanent motor
dysfunctions caused by non-progressive damage to the
developing brain. It is often accompanied by secondary
musculoskeletal impairments that can exacerbate activity
limitations [18]. Unilateral spastic cerebral palsy (USCP)
is the most common topographical presentation of cere-
bral palsy [1]. Most children with USCP are classified as
having a Gross Motor Function Classification System
(GMFCS) level of I or II [13]. This means that though
children are independently ambulant, they still have lim-
itations when walking in the community. This is largely
attributed to the common lower limb secondary muscu-
loskeletal impairments that are exacerbated with growth
in children with USCP. These include a combination of
gastrocnemius muscle spasticity, contracture, ankle dorsi-
flexion weakness and poor ankle selective motor control.
The combination of these impairments limits effective
foot clearance during the swing phase of gait and can
cause tripping or falling when walking [24].
Functional electrical stimulation (FES) applied to the
ankle dorsiflexors during the swing phase of gait can be
used to address problems with foot clearance. FES refers
to the application of neuromuscular electrical stimulation
to muscles that may not be able to contract voluntarily
within a task-specific functional activity such as walking
[12]. An electrical current is used to produce an involun-
tary muscle contraction by inducing an action potential
through the placement of two electrodes over the surface
of the skin above the target skeletal muscle [17].
Evidence to support the effectiveness of FES in chil-
dren with cerebral palsy has been increasing over recent
years, particularly because devices suitable for children
can now be purchased commercially. They are also more
user-friendly, enabling FES to be managed by children
and families in the community [11, 14, 15]. Common
outcome measurements used to evaluate the effective-
ness of FES have been focused mainly on the body struc-
ture and function level, which include range of motion,
spasticity, strength, muscle volume and gait mechanics
[7, 15, 19]. Although these measures have provided useful
clinical information, they are not able to indicate how FES
impacts the performance of individually specific daily
activities in the community and the satisfaction of the
user. Given that the application of FES during walking
enables the intervention to be applied in the commu-
nity, there is also a need to determine its effectiveness
within these environments.
The Canadian Occupational Performance Measure
(COPM) is a valid and reliable client-centred instrument
that provides the opportunity to evaluate self-perceived ef-
fectiveness of treatment whilst considering the individually
specific environment in which it is performed in [2, 5, 22].
Hence the COPM will also be used to evaluate thechanges in the self-perception of performance and sat-
isfaction of individually identified priorities following
daily FES during everyday walking activities.
The aim of this paper is to determine whether FES
in children with USCP is effective in improving self-
perceptions of individually identified mobility performance
problems when compared to children receiving usual
treatments. We hypothesized that children receiving
8 weeks of FES treatment would have higher scores
for self-perceived performance and satisfaction on the
COPM for individually identified priorities than chil-
dren not receiving FES. We also hypothesized that
children who received FES treatment would continue
to have higher scores for self-perceived performance
and satisfaction at follow-up than children not receiving
FES. The secondary aim of this study was to explore the
mobility performance of children with USCP by employ-
ing the International Classification of Functioning Child
and Youth version (ICF-CY) framework. This is clinically
important because an understanding of mobility per-
formance problems for children with USCP is needed
for family-centred service planning.Methods
Study design
The study design was a randomized controlled clinical
trial of daily FES during every day walking activities to
the ankle dorsiflexors compared with usual treatments
(control group).Participants
Participant inclusion criteria (Table 1) included: USCP,
Gross Motor Function Classification System [13] level
and Winters Gage and Hicks Classification [24] of I or
II, age 5 to 18 years, at least 5 degrees passive ankle
dorsiflexion and full knee extension, ability to co-operate
with the assessment procedures, and willingness to use
FES daily over 8 weeks. The schedule for study com-
mencement was dictated by current clinical care involving
botulinum toxin type A injections that is routinely deliv-
ered every 6 months. With the exception of 4 children
who do not have routine botulinum toxin type A injec-
tions (2 children in the treatment group and 2 children in
the control group), all remaining children have 6 monthly
botulinum toxin type A injections. For these children,
baseline measures commenced 3 months after injections
which is widely accepted to be after the peak technical
response due to motor end plate regeneration [8]. Par-
ticipants were excluded if they had orthopaedic surgery
performed on the affected side less than 12 months before
the study commenced, if they had orthopaedic metalware
at the site of stimulation, or if they had an uncontrolled
seizure disorder.
Table 1 Inclusion and exclusion criteria
Inclusion Criteria Exclusion Criteria
• Passive dorsiflexion range of
affected ankle of at least 5°
• History of uncontrolled seizure
disorder
• Full passive knee extension
bilaterally
• Orthopaedic lower limb surgery
on the affected side in the past
12 months
• Dynamic popliteal angle of no
more than 45°
• Orthopaedic metal ware at the
site of electrical stimulation
• Able to cooperate with
assessment procedures
• Botulinum toxin in lower limb in
the past 3 months
• Willing to use the Walk Aide ® at
least 4 h a day, 6 days a week for
8 weeks
• GMFCS I or II, unilateral spastic
cerebral palsy (with or without
dystonia)
• Winters Gage and Hicks gait
classification of Type I or II
• Aged between 5 and 18 years
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Paediatric Rehabilitation consultants between June and
July 2013 from clinics of the Cerebral Palsy Mobility Ser-
vice at Princess Margaret Hospital for Children and The
Centre for Cerebral Palsy in Perth, Australia. The trial
commenced in August 2013 with the final assessments
completed by April 2014. Ethics committees at Princess
Margaret Hospital for Children and The University of
Western Australia approved the trial. The committees’
recommendations were adhered to. Written and informed
consent for participation and publication was obtained
from all participants. This trial was retrospectively regis-
tered (ACTRN12614000949684). However no changes
were made to the protocol that was approved by the ethics
committees.
Procedure
An initial appointment was firstly arranged by the first
author (DP): a Physiotherapist, to determine FES tolerance
and discuss the study protocol. Randomization to either
the FES or control group was achieved through a coin
toss, by an individual uninvolved with the study once 2
matched participants were enrolled. Matched participants
were of the same GMFCS level, and were within 2 years of
age for children aged between 5 and 10, and within 6 years
for children aged between 11 and 18. This method was ap-
plied to improve the homogeneity of each group in terms
of age and gross motor function.
Outcome measures
The primary outcome measures were self-perceptions of
performance and satisfaction of individually prioritised
mobility performance problems derived from the COPM.The secondary outcomes were the categorization of the
priorities identified in the COPM and self-reported parent/
participant observations post treatment (FES group only
at post treatment) into the domains of the ICF-CY [25].
Canadian occupational performance measure
A single interviewer (JC): an Occupational Therapist
performed the COPM at all time points and was blinded
to group allocation. At baseline, the interviewer assisted
the child and family to identify occupational perform-
ance problems in the areas of self-care, productivity or
leisure. Once they had identified these problems, they
were written positively as goals, which participants and
their parents then prioritised by importance on a scale
from 1 to 10 (10 indicating greater importance). Scores
out of 10 for self-perceived performance and satisfaction
were then obtained from each participant (if the child
was 12 years or older) or parent (if the child was under
12 years). The scores were summed and averaged over
the number of priorities identified to produce two overall
scores out of 10 for each participant: one for performance
and one for satisfaction. At post-treatment and follow-up,
participants were blinded to their previous ratings in order
to limit potential bias [23]. A 2 point change in score on
the COPM is considered to be clinically meaningful [23].
Participant and parent self-report
At post-treatment, participants and their parents were
asked for written comments in answer to the question:
“Have you noticed any changes in yourself since using
the Walk Aide?” Again, parents answered on behalf of
children under 12 years.
FES intervention
Participants in the FES group received the FES device
after the baseline assessment. The Walk Aide® (Innovative
Neurotronics, Austin, TX, USA) is a small (8.2 cm x
6.1 cm x 2.1 cm, 87.9 g) device that delivers asymmetrical
biphasic surface electrical stimulation (ES) in a synchro-
nized manner to stimulate active dorsiflexion of the ankle
during the swing phase of gait. The Walk Aide® is attached
to the participant’s leg by a cuff and sits just below the
knee on the affected side. During a gait cycle, the Walk
Aide® stimulates the common peroneal nerve, which in-
nervates tibialis anterior and other ankle dorsiflexors
(extensor digitorum longus, peroneus tertius and exten-
sor hallucis longus). Ankle dorsiflexion was achieved by
the placement of one electrode over the fibular head to
stimulate the peroneal nerve and the other electrode
on the motor end point of tibialis anterior. Pulse width
was set to a maximum of 300 microseconds (μs) and
frequency was set at 33 hertz (Hz). Users could adjust
intensity (mA) using a dial on the device. The Walk
Aide’s® tilt sensor was individually synchronized and
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dorsiflexors could occur immediately after toe-off, remaining
activated during the swing phase of gait until initial
contact.
Weekly to fortnightly community physiotherapy home
and school visits were provided for parents and teachers/
education assistants to support FES use in different en-
vironments whilst ensuring correct use of the cuff and
accurate electrode placement. Participants were asked to
change electrodes every two weeks. Any adverse events
were to be reported immediately (via text message or
email) to the first author (DP) in order to ensure follow-
up in a reasonable time frame. Participants were asked to
use the FES device for at least 4 h a day, 6 days a week
during the 8-week treatment period. This was monitored
through the usage log on the device itself. To enable par-
ticipants an opportunity to accommodate to the device,
they were asked to build up gradually to the required dos-
age over the first week. The 8-week treatment period and
6-week follow-up period was chosen based on the results
from our pilot study [14] as well as around current clinical
care on the use of botulinum toxin injections (essentially
so that the study duration would not be interrupted by
botulinum toxin injections in an effort to minimize the
confounding effect of the injections to overall outcome).
Participants in the treatment group did not wear their
ankle foot orthosis (AFO) either during the FES treatment
phase or in the follow-up phase but where appropriate,
were provided with customized in-shoe orthosis at the
commencement of the study to support foot posture and
accommodate for leg length discrepancies. Participants in
the control group were asked to continue with their usual
orthotic protocol. To maintain consistent contact with the
participants, fortnightly home or school visits were also
provided for each participant in the control group.
Statistical analysis
Normality was established for the COPM scores through
examining distributional plots, Q-plots and the Shapiro-
Wilk Test. Means and standard deviations were reported
for each group for each phase. Within group differences
were assessed for a clinically meaningful change i.e. 2
point score change [23] from baseline. Between group
differences were examined using a repeated measures
ANOVA to account for the correlation between repeated
measures over time. Post-hoc Tukey’s test was applied if
a main effect for group and time or an interaction of
these was found, enabling adjustments for multiple com-
parisons and calculation of mean differences and 95 %
confidence intervals. Assumptions for the repeated ANOVA
were examined and met.
Statistical significant was accepted as p < 0.05. All statis-
tical analyses were performed using STATA version 12.1
(TestCorp, Texas).To further explore the performance components of
the identified priorities, each priority was analysed using
2 methods. Firstly, each priority was categorized by using
the occupational performance model i.e. relating to occu-
pational performance roles, areas or components [9, 10]
which secondly, facilitated the translation to the ICF-CY
to identify which domain or domains it addressed [16].
Two of the authors (DP and AMB) completed this process
with 92 % agreement (differences resolved by discussion).
Self-reported responses concerning overall impressions
of the FES device were compiled, thematically analysed
and categorized using the ICF-CY by 2 of the authors
(DP and AMB). Examples are presented verbatim.
Results
Thirty-two children, mean age 10 y 8 mo (range 5 y 5
mo – 18 y 1 mo) with USCP GMFCS level I or II were
recruited for the study. All participants had a Winters
Gage and Hicks gait classification of I or II indicating
foot clearance problems during walking gait. All partici-
pants completed the study in their original group allocation.
There were no missing data (Fig. 1).
There were no clinically meaningful differences between
the groups at baseline on the COPM (Table 2). Tests for
normality showed that COPM scores were approximately
normally distributed for performance (Shapiro-Wilk Test
p = 0.133, Skewness −0.79, Q-plot normal) and satisfaction
(Shapiro-Wilk Test p = 0.49, Skewness −0.36, Q-plot nor-
mal). Participants used the FES daily for a mean of 6.2 (SD
3.2) h over the 8-week intervention period. All participants
had a frequency set at 33Hz and pulse width ranging from
25-100 μs. There were no reported unintended effects or
adverse events using the FES device.
Primary outcome: COPM
There was a significant main effect for group (perform-
ance p < 0.001; satisfaction p < 0.001), time (performance
p < 0.001; satisfaction p < 0.001) and for interaction
of group and time (performance p = 0.003; satisfaction
p = 0.002). Post treatment, performance scores (mean dif-
ference 1.6, 95 % CI 0.1 to 3.2, p =0.034) and satisfaction
scores (mean difference 2.4, 95 % CI 0.5 to 4.2, p = 0.004)
were significantly higher in the treatment group than in
the control group. At follow-up, there were no significant
differences between the groups for performance scores
(mean difference 1.2, 95 % CI −0.4 to 2.8, p = 0.224). How-
ever, there was a significant difference between the groups
for satisfaction (mean difference 1.9, 95 % CI 0.1 to 3.8,
p = 0.030), again in favour of the treatment group.
From the baseline performance score in the treatment
group (3.97, SD 1.42), there were clinically meaningful
changes (i.e. >2 point change) post treatment (6.97, SD
1.04) and at follow-up (6.66, SD 1.57). From the baseline
satisfaction score in the treatment group (4.36, SD 1.69),
Fig. 1 Flow of participants through the trial. FES, Functional Electrical Stimulation
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ment (7.45, SD 1.34) and at follow-up (6.99, SD 2.11).
There was a trend for the control group having higher
scores at post treatment and follow-up than at baseline
for performance and satisfaction but these changes were
not clinically meaningful. These results are shown graph-
ically in Figs. 2 and 3.
Secondary outcome: ICF-CY classification of priorities
Participants in the study identified 1 to 3 priorities each.
There were a total of 80 individual priorities for the 32
participants. Some of the priorities involved more than 1
domain on the ICF-CY. For example, one of the prior-
ities was “to walk consistently with a heel to toe pattern
to improve my symmetry (so I don’t have to wear an
AFO)”. This included 2 parts involving (a) improving
walking mechanics (activity) (b) not need an AFO (per-
sonal). Hence, when the original 80 priorities were divided
into their component parts, there were 122 specific prior-
ities. These 122 priorities were categorized into bodystructure and function, activity and participation domains
as well as personal and environmental factors. As shown
in Table 3, 17 % of the priorities were directed towards the
need to improve impairments in body structure and func-
tion, 49 % were directed towards improving functional
mobility in the activities domain and 31 % were directed
towards improving community mobility and active recre-
ation in the participation domain.
Secondary outcome: ICF-CY classification of self-reported
changes in treatment group
ICF-CY analysis identified 5 major themes: (a) improved
running and walking (activity, n = 13); (b) improved com-
fort with more options to wear different shoes (personal
factor, n = 6) with comments such as “the walk aide means
less blisters on my feet, easier to put on shoes” and “her
dad got her ‘girlie’ shoes and they stay on her feet – really
pleased”; (c) reduction in trips and falls (participation,
n = 4), (d) improved confidence (personal factor, n = 4)
and; (e) increased foot awareness (body structure and
Table 2 Baseline characteristics of participants
Treatment Control p value
Weight (kg) 38.5 (15.2) 37.4 (15.9) 0.850a
Gender Male: 9 Male: 8
Female: 7 Female: 8
Side of hemiplegia Right: 11 Right: 12 0.950a
Left: 5 Left: 4
GMFCS I: 10 I: 10
II: 6 II: 6
WGH I: 1 I: 0
II: 15 II: 16
Age 10y 11mo 10y 5mo
(3y 10mo) (2y 8mo)
COPM
Performance 3.97 (1.42) 4.25 (1.42) 0.978a
Satisfaction 4.36 (1.69) 4.18 (0.99) 0.719a
a independent samples t test; GMFCS, Gross Motor Function Classification
System, WGH Winters Gage and Hicks, COPM Canadian Occupational
performance Measure
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of your foot placement when wearing the walk aide” and
“I can feel when it raises my toes when walking”.
The comments also yielded some disadvantages of the
Walk Aide® (n = 2) which included problems with the
size and difficulties in getting clothing to over it, causing
the cuff to “fall apart quite often”. Three of the partici-
pants did not wish to continue wearing Walk Aide® be-
yond the study period because of difficulties with accurateFig. 2 Mean and standard error of COPM Performance at baseline, post 8 w
between groups p<0.05placement, bulkiness, problems with wearing school uni-
forms (stockings or leggings), and difficulties in attaining a
good fit owing to the cuff sliding down the leg during
walking. The remaining 13 participants in the FES group
continued to use the Walk Aide® either as an AFO re-
placement or as an adjunct to their AFO protocol.
Participant 10 wrote a more detailed account of her
experiences post treatment:
“Although compared to many other cases, my CP is
quite mild, it has had quite an effect on me over the
years; mentally, physically and emotionally…. To be
honest I wasn't very keen on it in the beginning; I felt
like it added to the things that made me different…
but as the study progressed it quickly became the
thing that drew me closer to my peers. Emotionally, I
struggled with feeling different or out of place; having
to wear splints or orthotics, but through the use of
the Walk Aide, I began to feel more confident and
enthusiastic to do the things I had to do to maintain
the physical effects of the Walk Aide. The Walk Aide
for me, reduced, in fact eliminated my pain (foot, leg
and low back), boosted my confidence, gave me the
ability to wear shoes like thongs in summer (one of
my goals), increased my energy levels, and gave me
the ability to walk long periods of time without growing
weak or sore.”
Discussion
The FES group achieved significantly higher scores for
self-perceived performance and satisfaction on the COPMeeks Rx (treatment) and 6 weeks follow‐up; *significant difference
Fig. 3 Mean and standard error of COPM satisfaction at baseline, post 8 weeks Rx (treatment) and 6 weeks follow‐up; *significant difference
between groups p<0.05
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the first hypothesis, that FES is effective in improving self-
perceived performance and satisfaction of individually
identified mobility performance problems in children with
USCP. There has been limited support for the efficacy of
FES, particularly in regard to the activity and participation
domains of the ICF-CY. This has in part, been attributed
to the limited inclusion of valid and reliable activity and
participation outcome measures [3, 4]. Therefore, these
results not only provide unique evidence supporting
the effectiveness of FES on activity and participation
but also, that the results are consistent with current
knowledge on the effectiveness of FES on the main lower
limb impairments observed in children with USCP.
Currently, the literature supports that FES can improve
selective motor control, range of movement, spasticity,
strength and ankle kinematics during gait [11, 14, 15].
Therefore, it appears that by implementing FES during
daily walking activities, the main impairments affecting
gait in children with USCP are addressed alongside
quantifiable functional benefits reflected in the activity
and participation domains.
Children who received FES treatment continued to
have higher scores for self-perceived satisfaction, but not
for performance when compared to children not receiving
FES at follow-up. This partially supports the second
hypothesis. This is consistent with current findings
documenting that the effects of FES on muscular adapta-
tions are use-dependent [7]. This provides a plausible ex-
planation for why the self-perceived performance scoreswere no longer significantly improved in the treatment
group when compared to the control group at the 6 week
follow-up. However, this result also suggests that a period
of no FES (to a maximum of 6 weeks) can be incorporated
into the management plan for children with USCP with-
out significant detriment to the satisfaction of users. This
may be advantageous because of the potential to develop
dependence on the external stimulus replacing the in-
ternal control of movement [6]. Given that self-perceived
performance scores were no longer significantly higher in
the treatment group than in the control group at follow-
up, a non-use period greater than 6 weeks would not be
recommended. Alternating between FES use and non-use,
as adopted in this study, could be implemented to suit
individual and family needs such as planning around
holidays, school camps and seasons. Further study is
warranted to determine whether extending this regimen
would maintain the effects reported in the present study.
The secondary analysis of the priorities identified in
the COPM demonstrated that the majority of occupa-
tional performance problems for children and parents
were related to functional mobility activities, community
mobility and active recreation participation. However in
some instances, children and parents also identified
specific impairments in body structure and function.
Although the construct of the COPM facilitates the
identification of priorities more relating to activities
and participation, we included this data to reflect the
priorities of children and their parents. The inclusion
of priorities in this domain highlights that children
Table 3 Breakdown of the number (out of a total of 122) and
percentage of ICF-CY domains (alongside the occupational
performance components, areas and roles) in the identified
priorities









Sub Total 17 %
Activities Occupational Performance area
Functional Mobility
Improve walking mechanics 32
Improve walking endurance 6
Improve running 14
Improve high level gross motor skills 7
Sub Total 49 %
Participation





Keep up with friends 10
Improve sport performance 17
Sub Total 31 %
Environmental/Personal Factors
Wear certain kinds of shoes 3
Not need AFO 1
Sub Total 3 %
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function components that influence performance and
for Physiotherapists, the value of addressing them in
treatments. However, it also reinforces the importance
of clear and sensitive communication from clinicians,
realizing the influence of language on the priorities of
children and their parents.
In some instances, multiple domains were included
within each priority, reflecting the complexity and breadth
of outcome measures that would be required in order to
capture and quantify potential effects of treatment. Previ-
ous FES studies have reported discrepancies between the
outcomes of objective clinical outcome measures and the
more favourable parent reports [14, 20]. The complexity
of priorities may explain the discrepancy between clinicalobjective measures and parent report, because the object-
ive outcome measures emphasized body structure and
function assessed within a clinical environment. Hence
the outcome measures did not align closely with the prior-
ities of children and parents, which often emphasized ac-
tivities and participation in their own environment and
community.
The self-report also provided some additional insights
to (previously unreported) effects of FES after 8-weeks
of use. These included reports of improved confidence,
improved foot awareness, and improved range of foot-
wear. The results of this study support the effectiveness
of community applied FES to improve self-perceived
individually identified priorities, particularly when they
involve the performance of functional mobility, commu-
nity mobility and active recreation in children with USCP.
Considerations and recommendations for the use of daily
FES
Participants and their parents described some disadvan-
tages to wearing the FES device. Their comments indicated
that acceptance of the FES device goes beyond mere bio-
mechanical physical and compliance requirements. Because
the FES device needed to be strapped directly over skin,
there were issues with clothing, in particular leggings or
stockings for school uniforms. For younger children, the
combination of the cuff and device were bulky, and parents
struggled to find clothing to fit over it. Also for younger
children, the cuff fitting was an issue, as it would slide down
the leg during walking and running. Older children usually
managed these problems, but younger children needed
to have adequate support at home and school. When
prescribing the Walk Aide®, it is important to consider
the individually specific environmental factors that may
affect treatment. Therefore, providing information and
education to people involved in the child’s care is es-
sential. This highlights the importance of ensuring that
community therapy services are available and in place
prior to considering this intervention. However it should
be noted that the Walk Aide® is still essentially a device
that was specifically designed for adults. Though small
cuffs have been recently available, the size of the Walk
Aide® continues to be a potentially limiting factor for pa-
tient selection. Further investment into the technology
and fit of this device is recommended.
Future studies should consider the cost effectiveness
of this intervention. Although the cost-effectiveness of
FES in the adult population has been supported [21],
this has not been evaluated in children with USCP. For
some children, it may be appropriate for FES to replace
the use of AFOs. However, in other children, FES may
be an adjunct to current therapy and AFO intervention.
Evidently, this influences costs and should be evaluated
further. Further work is also warranted to develop a
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children to provide further perspectives on the effective-
ness of FES treatments.
There are some limitations to note. Although qualitative
self-report provided insights into the FES experience, it
was unstandardized, and so the comments must be
considered with some caution. Also, the outcomes of
the intervention were dependent on family and school
support. This could not be controlled and may have
varied across the participants.
Conclusions
Daily FES during everyday walking activities improves
self-perceptions of individually identified priorities, par-
ticularly involving the performance of activities, commu-
nity mobility and active recreation in children with USCP.
Alternating between a period of use and non-use may be
appropriate without detriment to the satisfaction of the
user, and this may be beneficial to suit family needs. The
role of community therapy is also highlighted for the edu-
cation and training of both families and teachers so that
this intervention can be successfully implemented within
each child’s own relevant environments.
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